ClinicalTrials.govpublic full text
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
follicular lymphoma, non-hodgkin's lymphoma, nhl, bay 80-6946, pi3k target, aliqopa, monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800299
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.